跳至主要内容
临床试验/NCT02653651
NCT02653651已完成4 期

A Comparison Between the Effects of Perioperative Intravenous Lidocaine and Ketamine on Acute and Chronic Pain After Open Nephrectomy: A Prospective, Double-blind, Randomized, Placebo Controlled Study

University Tunis El Manar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Total opioid consumption

研究概览

简要总结

Open nephrectomy is one of the most common surgical procedures in urologic practice. Pain after surgery remains a significant clinical problem as it impairs recovery adversely and may lead to the transition to chronic pain. The open approach represents a major physical trauma including postoperative pain and discomfort in the convalescence period. Adequate control of postoperative pain facilitates earlier mobilization and rehabilitation. Patient-controlled analgesia (PCA) is effective to treat pain at rest, but seems to be inadequate for dynamic analgesia and may also elicit side effects that may delay hospital discharge. Preventing early and late postsurgical pain is an important challenge for anesthesiologists and surgeons.

Ketamine (N-Methyl-D-Aspartate receptor antagonist) and lidocaine (sodium channel blocker) are popular analgesic adjuvants for improving perioperative pain management. The investigators designed this double-blind, placebo controlled study to test and compare the preventive effects of perioperative intravenous ketamine and lidocaine on early and chronic pain after elective open nephrectomy.

The investigators propose a double-blind placebo-controlled study of patients undergoing elective open nephrectomy. All patients will receive normal "patient-controlled analgesia morphine" in addition to study drugs or placebo. Research will be conducted at Charles Nicolle teaching hospital.

详细描述

Participants will be randomized into one of three study groups: Group L: intravenous lidocaine: bolus of 1.5 mg/kg at induction of anesthesia followed by infusion of 1 mg/kg/h intraoperatively and for 24 h postoperatively. Group K: Ketamine: bolus of 0.15 mg/kg followed by infusion of 0.1 mg/kg/h intraoperatively and for 24 h postoperatively. Control Group C: an equal volume of saline. The anesthetic technique will be standardized, and the postoperative assessments included pain scores, opioid consumption, recovery of bowel function and 6-minute walk distance (6-MWD) on the fourth postoperative morning. At 3 months, patients will be questioned for chronic postoperative pain using the Neuropathic Pain 4 questionnaire.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (>/=18)
  • male or female
  • Undergoing elective open nephrectomy
  • General anesthesia
  • Subject is American Society of Anesthesiologists (ASA) physical status 1 or 2.

排除标准

  • Pregnancy and breastfeeding
  • Cognitively impaired (by history)
  • Subject with a history of psychosis
  • Subject known to have significant hepatic disease
  • History of previous cardiac arrhythmia
  • Subject for whom opioids or ketamine are contraindicated

研究组 & 干预措施

Ketamine

Active Comparator

Ketamine infused at 0.1 mg/kg/hour

干预措施: Ketamine (Drug)

Lidocaine

Experimental

Lidocaine infused at 1 mg/kg/hour

干预措施: Lidocaine (Drug)

Placebo

Placebo Comparator

An equal volume of saline

干预措施: Placebo (Drug)

结局指标

主要结局

Total opioid consumption

时间窗: 24 hours

the total amount of morphine consumed during follow up period

次要结局

  • Postoperative nausea and vomiting using a Verbal Rating Scale(48 hours)
  • Functional recovery assessed by 6 minute walk test (6MWT)(the fourth postoperative morning)
  • chronic postoperative pain assessed by the Neuropathic Pain 4 questionnaire. (NP4)(At 3 months)

研究者

发起方
University Tunis El Manar
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ali JENDOUBI

MD, Assistant Professor

University Tunis El Manar

研究点 (1)

Loading locations...

相似试验